Expression of Tim-3/Galectin-9 pathway and CD8+T cells and related factors in patients with cystic echinococcosis

被引:0
作者
Zhao, Hui [2 ,3 ]
Ma, Yuyu [3 ]
Tian, Fengming [3 ]
Li, Bin [3 ]
Xiao, Ning [1 ]
Mo, Xiaojin [1 ]
Aibibula, Madinaimu [3 ]
Min, Hongyue [3 ]
Cai, Xuanlin [3 ]
Zhang, Ting [1 ]
Ma, Xiumin [3 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Chinese Ctr Trop Dis Res, Natl Inst Parasit Dis, NHC Key Lab Parasite & Vector Biol, Shanghai, Peoples R China
[2] Xinjiang Med Univ, Affiliated Hosp 1, Med Testing Ctr, Urumqi, Xinjiang, Peoples R China
[3] Xinjiang Med Univ, Tumor Hosp, Clin Lab Ctr, State Key Lab Pathogenesis Prevent & Treatment Hig, Urumqi 830011, Xinjiang, Peoples R China
关键词
Cystic echinococcosis; Tim-3/Galectin-9; pathway; CD8+T cells; CTL; CD8+CD28-T cells; IMMUNOGLOBULIN-G SUBCLASS; T-CELLS; RESPONSES; EXHAUSTION; TIM-3;
D O I
10.1016/j.exppara.2023.108623
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Objective: One of the primary reasons for the successful patriotization of Echinococcus multilocularis in patients is its ability to induce host immune tolerance. This study examined the expression of the immunosuppressive Tim-3/Galectin-9 pathway, CD8+T cells, and related factors in AE patients. The aim was to analyze the relationship between the Tim-3/Galectin-9 pathway and CD8+T cells in this disease and further understand the mechanism of immune tolerance induced by cystic echinococcosis. Methods: Using flow cytometry, we evaluated the expression of CTL, CD8(+)CD28-T cells, CD8(+)CD28 + IFN-gamma + T cells, CD8(+)CD28+perforin + T cells, CD8(+)CD28+granzyme B + T cells, CD8(+)CD28-IL-10 + T cells, CD8(+)CD28-TGF-beta+T cells, and Tim-3 expression on CD8+T cells in the peripheral blood of control (n = 30) and AE patients (n = 33). qRT-PCR was used to measure CD107a and Tim-3/Galectin-9 mRNA levels in PBMCs from the control and AE groups. Immunohistochemistry was employed to detect IL-10, TGF-beta, and Tim-3/Galectin-9 expressions in the infected livers of AE patients. Results: AE patients exhibited a significant decrease in peripheral blood CTL ratio (P < 0.001) and an increase in CD8(+)CD28+IFN-gamma+T cell ratio (P < 0.001). No significant changes were observed in the ratios of CD8(+)CD28+perforin + T cells (P = 0.720) and CD8(+)CD28+granzyme B + T cells (P = 0.051). The proportions of CD8(+)CD28-T cells (P < 0.001), CD8(+)CD28-IL-10 + T cells (P < 0.001), and CD8(+)CD28-TGF-beta+T cells (P < 0.001) were notably higher than in the control group. The expression of Tim-3 on CTL and CD8(+)CD28-T cells in AE patients was significantly upregulated (P < 0.001, P < 0.001). AE patients displayed a substantial decrease in peripheral blood PBMC CD107a mRNA levels (P < 0.001) and significant elevations in Tim-3/Galectin-9 mRNA levels (P < 0.001, P < 0.001). A negative correlation was observed between CD107a mRNA levels and both Tim-3 (r<^>2 = 0.411, P < 0.001) and Galectin-9 (r(2) = 0.180, P = 0.019) mRNA levels. Expressions of IL-10 (P < 0.001), TGF-beta (P < 0.001), and Tim-3/Galectin-9 (P < 0.001, P < 0.001) in AE patient-infected livers were significantly higher than in uninfected regions. IL-10 and TGF-beta expressions showed a positive correlation with Tim-3/Galectin-9. Conclusion" This study suggests that the high expression of Tim-3 on CD8+T cell surfaces in AE patients might promote an increase in CD8(+)CD28-T cells and related factors, while suppressing CTL and related factor expressions. This potentially induces the onset of immune tolerance, which is unfavorable for the clearance of Echinococcus multilocularis in patients, leading to the exacerbation of persistent infections.
引用
收藏
页数:10
相关论文
共 50 条
[41]   Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma [J].
Granier, Clemence ;
Dariane, Charles ;
Combe, Pierre ;
Verkarre, Virginie ;
Urien, Saik ;
Badoual, Cecile ;
Roussel, Helene ;
Mandavit, Marion ;
Ravel, Patrice ;
Sibony, Mathilde ;
Biard, Lucie ;
Radulescu, Camelia ;
Vinatier, Emeline ;
Benhamouda, Nadine ;
Peyromaure, Michael ;
Oudard, Stephane ;
Mejean, Arnaud ;
Timsit, Marc-Olivier ;
Gey, Alain ;
Tartour, Eric .
CANCER RESEARCH, 2017, 77 (05) :1075-1082
[42]   PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis [J].
Qiu, Ming-Ke ;
Wang, Song-Cun ;
Dai, Yu-Xin ;
Wang, Shu-Qing ;
Ou, Jing-Min ;
Quan, Zhi-Wei .
PLOS ONE, 2015, 10 (06)
[43]   Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients [J].
Fourcade, Julien ;
Sun, Zhaojun ;
Benallaoua, Mourad ;
Guillaume, Philippe ;
Luescher, Immanuel F. ;
Sander, Cindy ;
Kirkwood, John M. ;
Kuchroo, Vijay ;
Zarour, Hassane M. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (10) :2175-2186
[44]   Characterization of age-associated exhausted CD8+ T cells defined by increased expression of Tim-3 and PD-1 [J].
Lee, Kyoo-A ;
Shin, Kwang-Soo ;
Kim, Ga-Young ;
Song, You Chan ;
Bae, Eun-Ah ;
Kim, Il-Kyu ;
Koh, Choong-Hyun ;
Kang, Chang-Yuil .
AGING CELL, 2016, 15 (02) :291-300
[45]   Upregulation of TIM-3 and PD-1 on CD4+and CD8+T Cells Associated with Dysfunction of Cell-Mediated Immunity after Colorectal Cancer Operation [J].
Arai, Yosuke ;
Saito, Hiroaki ;
Ikeguchi, Masahide .
YONAGO ACTA MEDICA, 2012, 55 (01) :1-9
[46]   Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia [J].
Wang, Jun ;
Yang, Lu ;
Dao, Feng-Ting ;
Wang, Ya-Zhe ;
Chang, Yan ;
Xu, Nan ;
Chen, Wen-Min ;
Jiang, Qian ;
Jiang, Hao ;
Liu, Yan-Rong ;
Qin, Ya-Zhen .
LEUKEMIA & LYMPHOMA, 2022, 63 (01) :152-161
[47]   Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma [J].
Zhang, Tingting ;
Ren, Tianyuan ;
Song, Zheng ;
Zhao, Jing ;
Jiao, Lei ;
Zhang, Zhenzhen ;
He, Jin ;
Liu, Xianming ;
Qiu, Lihua ;
Li, Lanfang ;
Zhou, Shiyong ;
Meng, Bin ;
Zhai, Qiongli ;
Ren, Xiubao ;
Qian, Zhengzi ;
Wang, Xianhuo ;
Zhang, Huilai .
JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
[48]   TIM-3 as a potential exhaustion marker in CD4+ T cells of COVID-19 patients [J].
Modabber, Zahra ;
Shahbazi, Mehdi ;
Akbari, Roghayeh ;
Bagherzadeh, Mojgan ;
Firouzjahi, Alireza ;
Mohammadnia-Afrouzi, Mousa .
IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) :1707-1715
[49]   Expression of Inhibitory Receptors TIGIT, TIM-3, and LAG-3 on CD4+T Cells from Patients with Different Clinical Forms of Chronic Chagas Disease [J].
Ferragut, Fatima ;
Alcaraz, Paula B. ;
Beati, Paula ;
Girard, Magali C. ;
Ossowski, Micaela S. ;
Chadi, Raul ;
Fernandez, Marisa ;
Hernandez-Vasquez, Yolanda ;
Acevedo, Gonzalo R. ;
Gomez, Karina A. .
JOURNAL OF IMMUNOLOGY, 2023, 210 (05) :568-579
[50]   Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B [J].
Rong, Y. -H. ;
Wan, Z. -H. ;
Song, H. ;
Li, Y. -L. ;
Zhu, B. ;
Zang, H. ;
Zhao, Y. ;
Liu, H. -L. ;
Zhang, A. -M. ;
Xiao, L. ;
Xin, S. -J. ;
You, S. -L. .
TISSUE ANTIGENS, 2014, 83 (02) :76-81